FASEB Growth Factor Receptor Tyrosine Kinases Confence

FASEB 生长因子受体酪氨酸激酶会议

基本信息

项目摘要

DESCRIPTION (provided by applicant) This application is requesting partial funding to support the second offering of a unique FASEB Summer Research Conference on "Growth Factor Receptor Tyrosine Kinases in Mitogenesis, Morphogenesis, and Tumorgenesis" to be held at Snowmass Village, Colorado from August 4 to August 9, 2001. Based on the overall major success of the first FASEB Summer Research Conference on this subject held in the Summer 1999, the current Conference will continue to focus on new developments in the cell and molecular biology and pathophysiology of important classes of growth factor tyrosine kinases as they relate to mitogenesis, tissue regeneration and development, morphogenesis, tumorigenesis, progression, and invasion and metastasis. In line with the unanimous view of previous attendees, the erbB and Met families of receptor tyrosine kinases will again be emphasized. In addition, novel sessions will be held on extracellular matrix signaling, receptor tyrosine kinase domains and new small drug development, therapeutic targeting of receptor tyrosine kinases in malignant disease, growth factor therapy in non-malignant diseases, and on the biology and pathobiology of the Ron/Stk receptor tyrosine kinase. The Scientific Program will include platform presentations by 25 Invited Speakers, a majority of whom are renown leaders in the field. Moreover, the program will include a significant number of selected Abstract-driven oral presentations, as well as a Poster Session based on submitted abstracts. A Young Investigator Mini-Symposium, which proved to be a highly successful component of the first conference, will again serve as a highlight of the current conference. In order to provide a climate maximizing scientific interaction among the participants, conference attendance will be limited to between 100 and 195 investigators (including Invited Speakers), selected from applications based on their expertise and recent contributions to the scientific literature. Every effort will be made to insure a proper mix of established and young investigators, with women and minorities particularly encourage to participate. Like the first conference, this second conference is anticipated to be quite successful and to again serve as a state-of-the-art scientific forum on growth factor receptor tyrosine kinases that will foster opportunities for productive new research interactions as well as meet the high standards of a FASEB Summer Research Conference.
描述(由申请人提供) 此申请正在请求部分资金来支持第二次发行 独特的 FASEB 夏季研究会议“生长因子受体 酪氨酸激酶在有丝分裂、形态发生和肿瘤发生中的作用”即将举行 2001 年 8 月 4 日至 9 日在科罗拉多州斯诺马斯村举行。 第一届 FASEB 夏季研究会议在这方面取得了总体重大成功 该主题于 1999 年夏季举行,本届会议将继续关注 细胞和分子生物学以及病理生理学的新进展 生长因子酪氨酸激酶的重要类别,因为它们与 有丝分裂、组织再生和发育、形态发生、 肿瘤的发生、进展、侵袭和转移。 符合 先前与会者一致认为受体的 erbB 和 Met 家族 酪氨酸激酶将再次被强调。 此外,新颖的会议将 存在于细胞外基质信号传导、受体酪氨酸激酶结构域上 以及新的小药物开发,受体酪氨酸的治疗靶向 恶性疾病中的激酶、非恶性疾病中的生长因子疗法、 以及 Ron/Stk 受体酪氨酸激酶的生物学和病理学。 科学计划将包括 25 位受邀者的平台演讲 演讲嘉宾大多是该领域的知名领袖。 此外, 计划将包括大量精选的抽象驱动的口语 演示,以及基于提交摘要的海报会议。 一个 青年研究者小型研讨会非常成功 作为首届会议的组成部分,将再次成为本届会议的一大亮点 当前会议。 为了提供气候最大化的科学 与会者之间的互动,会议出席人数将受到限制 100 至 195 名调查员(包括特邀演讲者),选自 基于他们的专业知识和最近对 科学文献。 将尽一切努力确保适当的组合 成熟的和年轻的调查员,特别是女性和少数族裔 鼓励参与。 与第一次会议一样,第二次会议 预计将非常成功并再次成为最先进的 生长因子受体酪氨酸激酶科学论坛将促进 进行富有成效的新研究互动的机会以及满足 FASEB 夏季研究会议的高标准。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALPHONSE E SIRICA其他文献

ALPHONSE E SIRICA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALPHONSE E SIRICA', 18)}}的其他基金

The Cholangiocarcinoma Conference: Molecular Drivers, Microenvironment, and Precision Medicine
胆管癌会议:分子驱动因素、微环境和精准医学
  • 批准号:
    10747566
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
胆道癌中生长因子途径的改变
  • 批准号:
    7172654
  • 财政年份:
    2000
  • 资助金额:
    $ 1万
  • 项目类别:
ALTERED GROWTH FACTOR PATHWAYS IN BILLIARY CANCER
胆道癌中生长因子途径的改变
  • 批准号:
    6023971
  • 财政年份:
    2000
  • 资助金额:
    $ 1万
  • 项目类别:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
胆道癌中生长因子途径的改变
  • 批准号:
    6693829
  • 财政年份:
    2000
  • 资助金额:
    $ 1万
  • 项目类别:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
胆道癌中生长因子途径的改变
  • 批准号:
    6865103
  • 财政年份:
    2000
  • 资助金额:
    $ 1万
  • 项目类别:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
胆道癌中生长因子途径的改变
  • 批准号:
    7339683
  • 财政年份:
    2000
  • 资助金额:
    $ 1万
  • 项目类别:
ALTERED GROWTH FACTOR PATHWAYS IN BILLIARY CANCER
胆道癌中生长因子途径的改变
  • 批准号:
    6350400
  • 财政年份:
    2000
  • 资助金额:
    $ 1万
  • 项目类别:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
胆道癌中生长因子途径的改变
  • 批准号:
    7558284
  • 财政年份:
    2000
  • 资助金额:
    $ 1万
  • 项目类别:
Altered Growth Factor Pathways in Biliary Cancer
胆道癌中生长因子途径的改变
  • 批准号:
    8499770
  • 财政年份:
    2000
  • 资助金额:
    $ 1万
  • 项目类别:
Altered Growth Factor Pathways in Biliary Cancer
胆道癌中生长因子途径的改变
  • 批准号:
    8829763
  • 财政年份:
    2000
  • 资助金额:
    $ 1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了